If your skin could talk, it might whisper a startling truth: in the United States, skin cancer is so prevalent that more than 5.4 million cases are treated every year, making it the nation's most common cancer.
Key Takeaways
- In the United States, skin cancer is the most common cancer, with more than 5.4 million cases of basal and squamous cell skin cancer treated annually
- Globally, melanoma skin cancer causes around 57,000 deaths per year according to 2020 estimates
- About 1 in 5 Americans will develop skin cancer by age 70
- Solar urticaria affects 1 in 10,000 people
- Atopic dermatitis affects up to 20% of children and 3% of adults worldwide
- Acne vulgaris affects approximately 85% of adolescents aged 12-24
- Family history increases psoriasis risk 6- to 10-fold
- Smoking doubles the risk of psoriasis
- Obesity increases psoriasis risk by 20-50%
- Methotrexate remission rates for psoriasis reach 40% at 6 months
- Topical corticosteroids clear 80% of mild psoriasis cases
- Biologics like secukinumab achieve PASI 90 in 70-80% of psoriasis patients
- US dermatology visits increased 140% from 2005 to 2015
- Annual cost of atopic dermatitis in the US is $5.3 billion
- Psoriasis costs US $112 billion annually including indirect costs
Skin cancer is extremely common, but most cases are preventable with sun protection.
Economic and Societal Impact
1US dermatology visits increased 140% from 2005 to 2015
Verified2Annual cost of atopic dermatitis in the US is $5.3 billion
Verified3Psoriasis costs US $112 billion annually including indirect costs
Verified4Acne treatment market globally is projected to reach $13.66 billion by 2026
Directional5Skin disease burden accounts for 1.79% of global DALYs
Single source6Melanoma treatment costs average $153,000 per patient in the first year post-diagnosis
Verified7Nonmelanoma skin cancer Medicare costs exceed $1 billion yearly
Verified8Eczema absenteeism costs UK economy £1.2 billion annually
Verified9Global dermatology devices market was $12.8 billion in 2022
Directional10Hidradenitis suppurativa direct costs average $14,000 per patient yearly
Single source11Rosacea annual cost per patient in US is $3,775
Verified12Vitiligo quality of life impact is comparable to psoriasis
Verified13Alopecia areata causes $4,800 average productivity loss per patient
Verified14Skin cancers represent 40% of Medicare dermatology costs
Directional15Global anti-acne cosmetics market to hit $9.6 billion by 2027
Single source16Urticaria chronic cases lead to 7.8 work loss days per year
Verified17Biologics for psoriasis cost $30,000-$60,000 per patient annually
Verified18Teledermatology reduces costs by 20-30% vs in-person visits
Verified19Global alopecia market projected at $13.6 billion by 2030
DirectionalEconomic and Societal Impact Interpretation
The skin we're in is costing us a fortune, both in our wallets and our well-being, proving that while beauty may be only skin deep, the financial and human burdens of dermatological conditions cut right to the bone.
Prevalence and Incidence
1Solar urticaria affects 1 in 10,000 people
Verified2Atopic dermatitis affects up to 20% of children and 3% of adults worldwide
Verified3Acne vulgaris affects approximately 85% of adolescents aged 12-24
Verified4Psoriasis affects about 2-3% of the global population
Directional5Rosacea prevalence is estimated at 5.46% in the general population
Single source6Vitiligo impacts 0.5-2% of the world's population
Verified7Alopecia areata affects 2% of the population by age 50
Verified8Hidradenitis suppurativa prevalence is 0.05-4.1%
Verified9Seborrheic dermatitis affects 1-3% of the general population
Directional10Contact dermatitis accounts for 85-95% of occupational skin diseases
Single source11Urticaria (hives) has a lifetime prevalence of 20-25%
Verified12Eczema prevalence in children under 18 is 10.7% in the US
Verified13Melasma affects 1.5-33% depending on population
Verified14Lichen planus lifetime risk is about 1%
Directional15Pityriasis rosea incidence is 50-170 cases per 100,000 annually
Single source16Pruritus prevalence in general population is 8.1%
Verified17Bullous pemphigoid incidence is 6-13 per million per year in Europe
Verified18Globally, acne affects 9.4% of the population
Verified19Hand eczema point prevalence is 4% in the general population
Directional20Oral lichen planus affects 0.5-2.2% lifetime
Single source21In the US, 31.6 million people have eczema
Verified22Fungal infections like tinea pedis affect 10-20% of the population
Verified23Herpes zoster lifetime risk is 30% by age 80
Verified24Scabies global prevalence is 200 million cases annually
Directional25Impetigo incidence in children is up to 12.3% in low-income settings
Single source26Keloids affect 5-15% in darker skin types
VerifiedPrevalence and Incidence Interpretation
It seems our skin, in its vast and varied rebellion, has ensured that virtually every human will at some point negotiate terms with it, making dermatology less a specialty and more a universal human experience.
Risk Factors and Causes
1Family history increases psoriasis risk 6- to 10-fold
Verified2Smoking doubles the risk of psoriasis
Verified3Obesity increases psoriasis risk by 20-50%
Verified4UV radiation exposure is the top modifiable risk for skin cancer
Directional5Fair skin (Fitzpatrick type I-II) has 100 times higher melanoma risk than dark skin
Single source6History of sunburns before age 20 doubles melanoma risk
Verified7Immunosuppression increases nonmelanoma skin cancer risk 65-250 fold
Verified8HPV infection is linked to 90% of cutaneous squamous cell carcinomas
Verified9Dairy consumption may increase acne risk by 20-30% due to IGF-1
Directional10High glycemic load diet raises acne risk by 49%
Single source11Staphylococcus aureus colonization precedes atopic dermatitis flares in 90% of cases
Verified12Filaggrin gene mutations increase atopic dermatitis risk 3-5 fold
Verified13Arsenic exposure in drinking water increases skin cancer risk 20-fold
Verified14HIV infection increases Kaposi sarcoma risk dramatically
Directional15Nickel allergy causes 14-20% of contact dermatitis cases
Single source16Genetic predisposition accounts for 60-90% of vitiligo risk
Verified17Stress exacerbates rosacea in 79% of patients
Verified18Demodex mites are present in 100% of severe rosacea cases
Verified19Oral contraceptives with antiandrogens reduce acne recurrence by 50%
Directional20Childhood antibiotic use increases eczema risk by 40%
Single source21Heliobacter pylori infection correlates with rosacea in 50% of cases
Verified22Pesticide exposure raises Parkinson's and skin cancer risk
VerifiedRisk Factors and Causes Interpretation
Your family history, diet, and habits write a startlingly clear prescription for your skin's future, so while you can't change your genes, you certainly shouldn't smoke on their behalf.
Skin Cancer Statistics
1In the United States, skin cancer is the most common cancer, with more than 5.4 million cases of basal and squamous cell skin cancer treated annually
Verified2Globally, melanoma skin cancer causes around 57,000 deaths per year according to 2020 estimates
Verified3About 1 in 5 Americans will develop skin cancer by age 70
Verified4UV exposure causes 90% of nonmelanoma skin cancers and 65% of melanomas
Directional5In 2023, an estimated 97,610 new cases of invasive melanoma will be diagnosed in the US
Single source6Men have a 1 in 27 lifetime risk of developing melanoma, compared to 1 in 40 for women
Verified7Indoor tanning increases melanoma risk by 75% for those who start before age 35
Verified8Basal cell carcinoma accounts for about 80% of all skin cancers in the US
Verified9Squamous cell carcinoma represents about 20% of nonmelanoma skin cancers
Directional10Globally, there were 1.2 million new cases of melanoma in 2020
Single source11In Australia, skin cancer represents 80% of all newly diagnosed cancers
Verified12White individuals have a 24 times higher risk of melanoma than Black individuals
Verified13Actinic keratosis, a precancerous lesion, affects 10,000 Americans daily
Verified14Merkel cell carcinoma incidence has tripled from 1986 to 2011 in the US
Directional15Survival rate for melanoma diagnosed early (localized) is 99%
Single source16In Europe, melanoma incidence rates vary from 3.8 to 29.6 per 100,000 for men
Verified17Tanning bed use before age 20 increases melanoma risk by 47%
Verified18Nonmelanoma skin cancers cost the US over $8.1 billion annually in treatment
Verified19Kaposi sarcoma incidence rose 30-fold during the AIDS epidemic
Directional20In the UK, melanoma rates have increased by 158% since the early 1990s
Single source21Women aged 25-29 have the highest melanoma incidence rate in some countries
Verified22Genetic mutations like CDKN2A increase melanoma risk 50-fold
VerifiedSkin Cancer Statistics Interpretation
The sun, in its infinite generosity, offers a 1 in 5 chance of gifting Americans a skin cancer diagnosis by age 70, a statistically grim souvenir from a star we foolishly treat like a tanning bed.
Treatment and Management
1Methotrexate remission rates for psoriasis reach 40% at 6 months
Verified2Topical corticosteroids clear 80% of mild psoriasis cases
Verified3Biologics like secukinumab achieve PASI 90 in 70-80% of psoriasis patients
Verified4Isotretinoin clears severe acne in 85% of patients after one course
Directional5Mohs surgery has 99% cure rate for basal cell carcinoma
Single source6Photodynamic therapy success for actinic keratosis is 77-89%
Verified7Dupilumab reduces atopic dermatitis severity by 75% in 50% of patients
Verified8Laser therapy improves melasma by 50-75% in 60% of cases
Verified9Cryotherapy cures 85-90% of warts
Directional10Minoxidil 5% promotes hair regrowth in 40% of androgenetic alopecia cases
Single source11Narrowband UVB achieves 75% clearance in vitiligo repigmentation
Verified12Botulinum toxin reduces hyperhidrosis by 80-90%
Verified13Excimer laser clears 75% of psoriasis plaques
Verified14Topical calcineurin inhibitors remit 70% of facial atopic dermatitis
Directional15Fractional CO2 laser improves acne scars by 50-70%
Single source16Imiquimod clears 45-85% of actinic keratoses
Verified17JAK inhibitors like abrocitinib achieve EASI-75 in 43-62% of atopic dermatitis patients
Verified18Microneedling with PRP improves alopecia areata in 70% of cases
Verified19Oral ivermectin cures 96% of scabies cases
Directional20PUVA therapy achieves 80-90% clearance in psoriasis
Single source21Teledermatology improves access, with 92% concordance to in-person diagnosis
VerifiedTreatment and Management Interpretation
If you view our dermatological arsenal as a set of power tools, then teledermatology is the universal adapter that ensures we can plug the right one—be it the sledgehammer of biologics or the precision scalpel of Mohs—into the exact spot of your skin’s revolt, with a confidence that verges on the clairvoyant.
Sources & References
- Reference 1AADaad.orgVisit source
- Reference 2WHOwho.intVisit source
- Reference 3SKINCANCERskincancer.orgVisit source
- Reference 4CANCERcancer.orgVisit source
- Reference 5GCOgco.iarc.who.intVisit source
- Reference 6CANCERcancer.org.auVisit source
- Reference 7CDCcdc.govVisit source
- Reference 8NCBIncbi.nlm.nih.govVisit source
- Reference 9ECISecis.jrc.ec.europa.euVisit source
- Reference 10JAMANETWORKjamanetwork.comVisit source
- Reference 11CANCERRESEARCHUKcancerresearchuk.orgVisit source
- Reference 12IARCiarc.who.intVisit source
- Reference 13DERMNETNZdermnetnz.orgVisit source
- Reference 14PSORIASISpsoriasis.orgVisit source
- Reference 15PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 16NAAFnaaf.orgVisit source
- Reference 17JACIONLINEjacionline.orgVisit source
- Reference 18AAFPaafp.orgVisit source
- Reference 19NATIONALECZEMAnationaleczema.orgVisit source
- Reference 20NEJMnejm.orgVisit source
- Reference 21GRANDVIEWRESEARCHgrandviewresearch.comVisit source
- Reference 22FORTUNEBUSINESSINSIGHTSfortunebusinessinsights.comVisit source
- Reference 23ALLIEDMARKETRESEARCHalliedmarketresearch.comVisit source